Dog Degenerative Myelopathy: Progressive Disability Welfare

Degenerative myelopathy is a progressive neurological disease affecting large and giant breed dogs, causing gradual paralysis and raising complex welfare decisions for owners and vets.

Key Facts

DM is caused by a mutation in the SOD1 gene, highly prevalent in German Shepherds, Corgis, and Boxers
The disease progresses from hindlimb weakness to complete paralysis over 6-18 months
There is no effective treatment to halt or reverse DM progression
Affected dogs typically maintain normal pain sensation until late-stage disease
Physiotherapy and assisted mobility devices (wheels) can extend quality of life significantly
The disease eventually affects the forelimbs and respiratory muscles, becoming life-limiting

Welfare Considerations

Degenerative myelopathy creates a prolonged period of progressive disability that challenges owners and vets to maintain quality of life through deteriorating function. Dogs with DM typically remain pain-free but experience loss of independence, mobility, and normal social behaviour. Urinary and faecal incontinence cause hygiene distress. Regular welfare assessment using quality of life frameworks helps owners make timely euthanasia decisions. Genetic testing before breeding can reduce DM incidence in high-risk breeds.

What You Can Do

Genetic test dogs of high-risk breeds before breeding to reduce DM incidence
Learn quality of life assessment tools to guide welfare decisions through disease progression
Consult veterinary neurologists and rehabilitation specialists for DM management
Provide mobility aids and physiotherapy to extend comfort and function for affected dogs
Support charitable research into DM treatment and genetic prevention